logo-loader

NA Proactive news snapshot: American Manganese, Blackrock Gold, Aftermath Silver, Phunware, PreveCeutical Medical, Gold Resource Corporation UPDATE...

Last updated: 16:56 04 May 2020 EDT, First published: 10:15 04 May 2020 EDT

Newspapers and laptop

American Manganese Inc (CVE:AMY) (OTCPINK:AMYZF) will host its annual general meeting (AGM) of shareholders by audio teleconference only, rather than an in-person meeting in the light of the global pandemic, the company said in a brief statement. This will be held on May 13 this year at 11 am PT. The North American toll-free number is 1-888-433-2192, while the participant code is 2820113. The company encourages shareholders to ahead of the meeting using the voting instruction form or the form of proxy mailed to them with the meeting materials, it added.

Blackrock Gold Corp (CVE:BRC) has received a 'buy' rating from Brien Lundin in the May issue of his Gold Newsletter, after he started covering the stock. Last month, the firm unveiled plans for an initial 7,000 metre drill campaign at its Tonopah West project at the famous Walker Lane trend in Nevada, earmarked to begin in June this year. The previously worked Tonopah silver district produced 174 million ounces of silver and 1.8 million ounces of gold, but land ownership became fractionalized. Lundin noted that a recent consolidation effort by Ely Gold Royalties (CVE:ELY) had pulled most of those claims back together, and it’s this consolidated group that the firm has optioned as Tonopah West. He says the area has seen little in the way of modern exploration and that targets left behind from Tonopah West’s production heyday are simply strike and dip extensions of well-defined, historic veins. "With potentially intriguing results from that deep hole at Silver Cloud due in the coming weeks, Blackrock boasts both short-term news flow and a major new property acquisition that isn’t currently reflected in the company’s market cap. It’s a buy at current levels," said Lundin.

Virtual Investor Conferences, the proprietary virtual event series from OTC Markets Group Inc.(OTCQX:OTCM), along with co-sponsor Red Cloud Securities Inc, released the agenda Monday for it’s upcoming Metals & Mining Virtual Investor Conference on May 6-7. The event will connect individual and institutional investors, advisors and analysts with the executive management teams of more than 30 global metals and mining companies. The program is scheduled to begin at 8:45 am ET on Wednesday, May 6 and Thursday, May 7.

Aftermath Silver Ltd (CVE:AAG) (OTCQB:FLMZF) welcomed a new shareholder in the form of Canadian resource-focused merchant bank Palisades Goldcorp. The junior silver exploration company said Monday that Palisades purchased 7.5 million units at C$0.20 per unit, giving Palisades around 10.4% ownership. The financing netted Aftermath gross proceeds of C$1.5 million, which will be used primarily for maintenance costs at its Challacollo and Cachinal silver-gold projects in Chile and business development activities.

Phunware Inc’s (NASDAQ: PHUN) mobile Pandemic Response Solution for the healthcare industry, backed by the power of its Multiscreen-as-a-Service (MaaS) platform, has been deployed in New York. In a statement Monday, the company said its mobile healthcare solution was launched at one of the largest teaching hospitals in the US. The system will not only enhance the patient experience but also address critical challenges clinicians now face as they respond to the ongoing coronavirus (COVID-19) pandemic. Phunware said this is the first deployment of its pandemic response solution for healthcare for an existing customer since it announced the rollout on April 7. 

PreveCeutical Medical Inc (CSE:PREV) (OTCQB:PRVCF) announced Monday that the company is working on an extension of its cannabis sol-gel nasal program to address the coronavirus (COVID-19) pandemic. The program extension will focus on the expedited development of a CBD sol-gel to potentially reduce the possibility of coronavirus infections. The technology works by infusing cannabis extracts into water-based sol-gels, which are delivered using a nasal spray applicator.

Gold Resource Corporation (NYSEAMERICAN:GORO) will host a conference call for investors to discuss the miner’s first quarter earnings on Wednesday, May 6 at 11am EST. CEO Jason Reid will chair the discussion, which will include a discussion of the company’s quarterly results and an update on current operations. The gold and silver producer has operations in Oaxaca, Mexico and Nevada and has returned $114 million to its shareholders in consecutive monthly dividends since July 2010.

GlobeX Data Ltd (CSE:SWIS) (OTCMKTS:SWISF) has launched a new sales campaign in the USA and Canada to promote its cyber security and privacy solutions as the world grapples with the coronavirus pandemic. In a statement Monday, the tech firm said it had contacted 300 qualified resellers of cloud and security solutions in both countries as demand for these offerings has increased exponentially.

Genprex Inc (NASDAQ:GNPX) CEO Rodney Varner told shareholders Monday that the clinical-stage gene therapy company’s near-term future “could be transformational.” In a letter, Varner said the company is bullish going forward as it further develops its lead drug candidate Oncoprex to treat non-small cell lung cancer (NSCLC) and secures the necessary capital to carry out its business strategy for at least two years. Oncoprex recently won Fast Track Designation from the US Food and Drug Administration, in combination with osimertinib for the treatment of patients with NSCLC.

Nextleaf Solutions Ltd (CSE:OILS) announced that it has been issued patents in Germany, France and the UK related to its CBD oil extraction technology. The company’s method of extracting and separating cannabinoids and terpenes makes it possible to purify and concentrate the desired compounds, which can be used for the manufacturing of a diverse array of products standardized for dose, the company said. Over the past year, the company has been granted 24 issued patents and possesses more than 60 pending patents related to the extraction, purification and formulation of cannabinoids. 

Champignon Brands Inc (CSE:SHRM) (OTCQB:SHRMF) announced a new North American clinical expansion committee as part of its plan to open five new clinics in the US this year. The Vancouver-based company said that the committee is tasked with accelerating its US expansion plan, where it is in the midst of discussions with revenue-generating clinics in six states. In a statement, Champignon said it hopes to capitalize on the fragmented nature of the US ketamine clinic marketplace to create a consortium of integrated mood disorder treatment and research facilities.

Seelos Therapeutics Inc (NASDAQ:SEEL) shares advanced on Monday as the biopharma group reported on patent news for its SLS-005 drug, known as trehalose. The group is focused on advancing various therapeutics to address unmet medical needs for central nervous system (CNS) disorders and other rare conditions. In a brief statement, Seelos said it had received a 'Notice of Allowance' from the United States Patent and Trademark Office (USPTO) to allow claims, which cover the composition of matter and method of use for trehalose (SLS-005) for a number of conditions.

Hill Street Beverage Company Inc (CVE:BEER) closed a C$1 million financing to support the company’s plans to launch cannabis-infused beverages in North America. CEO Terry Donnelly said in a statement Monday that the financing “demonstrates the confidence leadership team and board have in the company's plans and ability to execute on our vision.” The financing’s principal subscribers included Donnelly and the Toronto-based company’s largest shareholder, HoldCo St Catharines Ltd.

Co-Diagnostics Inc (NASDAQ:CODX), a molecular diagnostics company, announced Monday that its coronavirus (COVID-19) diagnostic test has been approved for sale by government agencies in Mexico and India.  In a statement, the Salt Lake, Utah-based company said the Mexican Department of Epidemiology (InDRE) has approved its Logix Smart COVID-19 test after it successfully concluded an evaluation of the test's sensitivity and specificity and its non-reactivity with other respiratory viruses. Meanwhile, Co-Diagnostics also announced that CoSara, the company's joint venture for manufacturing in India, expects to "now begin filling orders" following the successful evaluation of CoSara's Saragene COVID-19 RT-PCR test kit by the Indian Council of Medical Research (ICMR).

Bragg Gaming Group Inc (CVE:BRAG) (OTCMKTS:BRGGF) has inked a definitive share purchase agreement with SN&CK Media Limited (SML) for the sale of its media division, including GiveMeSport (GMS), following the completion of a strategic review of its online media division. Under the sale agreement, Bragg said it will receive total consideration of up to £400,000 (C$699,801), consisting of an upfront cash payment of £50,000 (C$87,465), in addition to 10% of the gross revenues from the media division for a period of 21 months following completion, which is expected in early May 2020.

EuroLife Brands Inc (CSE:EURO) (OTCMKTS:EURPF) (FSE:3CMA) has revealed it is on the hunt for an eighth retail location in Europe to sell health and wellness goods as it continues its bid to grow its business in the region. The move comes after the group's recent deal to buy CWE, which owns and operates HANF Hemp Stores in Germany and Luxembourg, announced earlier this month.

CytoDyn Inc (OTCQB:CYDY) has told investors that it expects to complete enrolment for the Phase 2 trials of its leronlimab drug as a potential coronavirus treatment by the end of May, which is a double-blinded, placebo-controlled trial for 75 patients. Additionally, CytoDyn said, it has submitted a request to the US Food and Drug Administration (FDA) for expanded access, known as compassionate use, that would make leronlimab available to patients who do not qualify for the clinical trial. Many severely ill coronavirus patients who have received off-label treatments were excluded from the trials but could potentially benefit from using leronlimab through compassionate use, it said.

GR Silver Mining Ltd (CVE:GRSL) (OTCQB:GLYXF) has reported additional high-grade drill results at its Plomosas Silver Project in Sinaloa, Mexico.    The company said the results are located in the San Juan area, one of six priority areas, that indicate continuity of the high-grade silver-gold mineralization on a step-out section, 100 miles north of drill holes previously reported. The new drill results included an intersection of 2.7 metres (m) at 1,304 grams per ton (g/t) silver equivalent and 3.6m at 675 g/t silver equivalent, according to GR Silver.

Antibe Therapeutics Inc (CVE:ATE) (OTCQB:ATBPF) has told shareholders that it expects to release topline results from the Phase 2B study of its flagship pain drug ATB-346 within six weeks. The company said that its clinical research organization Veristat completed the trial and was able to capture all patient data from 360 participants across 40 clinical sites. Toronto-based Antibe’s original timeline to release results was impacted by the ongoing coronavirus (COVID-19) pandemic that caused governments and healthcare providers to impose hospital restrictions and clinic closures.

Osino Resources Corp (CSE:OSI) has revealed that its 20,000 metre (m) drill program at the Twin Hills Central Discovery in Namibia will begin again after being on hold for a month due to coronavirus pandemic restrictions. In a statement, the firm said work will start again on May 5, with diamond drilling and the IP survey at the prospect getting underway shortly after, and it reiterated that it aims to complete the exploration program before the end of 2020.

Lexaria Bioscience Corp (CSE:LXX) (OTCQX:LXRP), a global innovator in drug delivery platforms, has struck definitive agreements with qualified investors for the sale of 8,978,260 shares and warrants via a private placement to drum up proceeds of over US$2 million to boost its flagship DehydraTECH technology. The company said the shares are being issued at a price of US$0.23 each, with the warrants immediately exercisable at a price of US$0.35 per share with a five-year term until expiry. The company said a portion of the funds will be used for completing a human pilot study researching the effectiveness of DehydraTECH to “enhance the oral bioavailability of certain antiviral drugs” with the potential of combatting the coronavirus (COVID-19) and other infectious diseases. The rest of the money will drive the application process for a senior US exchange listing application, and for working capital, the company added.

Neo Lithium Corp (CVE:NLC) (OCTMKTS:NTTHF) has said it continues to operate its 3Q project in Catamarca Province, Argentina under strict measures due to the coronavirus pandemic and has the cash to move it into full development. In an update on its operations, the firm said its aims were to maintain production of 3%-4% lithium brine from the project, continue the optimization of processing at the pilot plant in Fiambalá, and move closer to full development of the property.

Hillcrest Petroleum Ltd (CVE:HRH) (OTCMKTS:HLRTF) had said it is to formalise a joint venture that will market a potentially transformational electrical generation technology. The group said the partnership with Oropass Ltd, which has been granted USA licensing rights by the owner of the intellectual property, will be held on a 50/50 basis and is an important step in monetising the technology. The creation of the joint venture follows the signing of a Letter of Intent (LOI) and payment of a cash deposit by Hillcrest last month. The partnership intends to market the technology to the electrical equipment manufacturing industry, with an initial focus on electric vehicle (EV) and power generation equipment manufacturers.

InnoCan Pharma Corporation (CSE:INNO) has announced that cell and gene therapy specialist Professor Daniel Offen had been appointed to its scientific advisory committee following the firm's tie-up with Tel Aviv University company, Ramot. Professor Offen works at the Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Sagol School of Neuroscience at Tel Aviv University.

Exactus Inc (OTCQB:EXDI), a leading producer of hemp-derived ingredients, announced Monday the appointment of Larry Wert, former president of Tribune Broadcast Media, to its board of directors. Wert, who left Tribune in September 2019 after it was sold, will help Florida-based Exactus as it seeks to become a top player in the global hemp industry with its cannabidiol (CBD) and cannabigerol (CBG) products.

Great Bear Resources Ltd (CVE:GBR) (OTCQX:GTBDF) has drilled one of the longest high grade intervals to date on its flagship Dixie project in Red Lake, Ontario. The company reported new results Monday from its mammoth 300-hole drill program, including drill hole BR-118 on the LP Fault zone that was completed in the middle of a 150 metre gap in drilling. The drilling intersected two significant mineralized intervals of 10.2 grams per ton (g/t) gold over 6.8 metres and 18.6 g/t gold over 13 metres. Both intervals were within broader intervals of 3.2 g/t gold over 57 metres and 2.7 g/t gold over 104.2 metres respectively.

Great Bear Resources also said it has received a final order from the Supreme Court of British Columbia dated April 28, 2020, and shareholder approval on April 23, 2020, for its proposed plan of arrangement to reorganize its business, including the spinoff of its wholly-owned subsidiary, Great Bear Royalties Corp. There is no change in the Great Bear Resources' name and no consolidation of capital as a result of the arrangement. The plan of arrangement is fully described in Great Bear Resources' information circular dated March 16, 2020.

Pacton Gold Inc. (CVE:PAC) said the TSX Venture Exchange has accepted for filing documentation pertaining to two option agreements, dated April 23, 2020, and April 24, 2020, between the company and two arm's-length parties, whereby the company has been granted an option to acquire a 100% right, title and interest in certain minerals claims, the Swain Lake and Red Lake West properties, located in the Red Lake mining district of Ontario.

Klondike Gold Corp (CVE:KG) said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement, announced on April 14, 2020, which will see the issue of 3,205,643 common shares and 3,481,579 flow-through shares at purchase prices of 17.5 cents per common share and 19 cents per flow-through share, together with 6,687,222 share purchase warrants with an exercise price of 25 cents for a two-year period with 16 placees.

Metalla Royalty & Streaming Ltd. (CVE:MTA) (NYSEAMERICAN:MTA) announced that it has filed a final short form base shelf prospectus which, when made effective, will enable the company to make offerings of up to C$200 million of common shares, warrants, subscription receipts, units and share purchase contracts or a combination thereof from time to time, separately or together, in amounts, at prices and on terms to be determined based on market conditions at the time of the offering during the 25-month period that the prospectus remains effective.

Metalla also announced that it has retained Generation IACP Inc. to provide market-making services with the objective of maintaining a reasonable market and improving the liquidity of the company's common shares. Under the agreement, Metalla has agreed to initially pay Generation a fee of $7,500 plus applicable taxes per month. The initial term of the Generation agreement will last six months and such term will be automatically renewed for subsequent six-month periods unless terminated earlier by 30 days of prior written notice.

Matinas BioPharma Holdings, Inc. (NYSEAMERICAN:MTNB), a clinical-stage biopharmaceutical company, has said it will host a conference call and live audio webcast on Monday, May 11, 2020, at 4.30pm ET to discuss operational and financial results for the first quarter ended March 31, 2020. To participate in the call, please dial (877) 407-5976 (domestic) or (412) 902-0031 (international). The live webcast will be accessible on the Investors section of Matinas’ website, www.matinasbiopharma.com, and will be archived for 90 days

Aurania Resources Ltd. (CVE:ARU) (OTCQB:AUIAF) said its president, Dr Richard Spencer will present at VirtualInvestorConferences.com on Thursday May 7, 2020, at 2.00pm ET. This will be a live, interactive online event where investors are invited to ask the company questions in real-time. The group has invited individual and institutional investors, shareholders, as well as advisors and analysts, to attend real-time, interactive presentations via the following link: https://tinyurl.com/MayResourceVIC-PR

OTC Markets Group Inc. (OTCQX:OTCM), operator of financial markets for 10,000 U.S. and global securities, announced that Turmalina Metals Corp. (CVE:TBX) (OTCQX:TBXXF), an exploration company, has qualified to trade on the OTCQX Best Market and has today upgraded from the OTC Pink market. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their US investors. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws. Turmalina chief executive officer, Dr Rohan Wolfe, commented: "Turmalina is pleased to join the OTCQX Market, a move that will make trading easier and more transparent for our U.S. investors. Turmalina has an exciting portfolio of high-grade gold-copper assets in South America, and we look forward to informing the market of our upcoming drilling program."

Phunware, Inc. (NASDAQ:PHUN) announced that BUYINS.NET, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on the company after releasing the latest data in the stock through April 30, 2020. The group said the total aggregate number of its shares shorted since February 2019 is approximately 92.3 million shares, while on average approximately 47.31 % of the daily trading volume is short selling, and the SqueezeTrigger price for all Phunware shares shorted is $2.61. - a short squeeze is expected to begin when shares of PHUN exceed this level. BUYINS.NET monitors Phunware market-makers daily for compliance with Fair Market-Making Requirements, while its Friction Factor calculates if a fair market is being made in the shares of Phunware. The group said the reports show 48% of the previous 40 trading days have been positive or bullish-biased and 5% have been negative or bearish-biased.

ARway.ai announces multiple new SaaS developer contracts in both the United...

ARway.ai (CSE:ARWY, OTCQB:ARWYF) Chief Executive Officer Evan Gappelberg joined Steve Darling from Proactive to announce multiple new SaaS developer sign-ups for its augmented reality experience platform, focusing on AR indoor navigation. These partnerships represent significant milestones in...

1 hour, 35 minutes ago